因塞特高管表示:到2030年,剔除Jakafi后的核心业务规模有望达到当前Jakafi水平

美股速递
Feb 10

在最新电话会议中,因塞特医疗高层透露,公司旗下除明星产品Jakafi以外的核心业务管线展现出巨大增长潜力。该高管预测,若发展符合预期,这部分业务到2030年时有望达到与当前Jakafi同等规模的市场地位。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10